BMI’s influence on disease pathogenesis uncovered in new research

The study highlights BMI’s role in mediating genetic risk for diseases, suggesting a complex relationship with conditions like heart failure and osteoarthritis.

Shorla acquires methotrexate solution from Therakind in the US – Pharmaceutical Technology

Shorla raised $35m earlier this month to advance its oncology pipeline. Credit: zorazhuang via Getty Images. Shorla Oncology has acquired the oncology and autoimmune drug

October 31, 2023

Juul spent big to court Black leaders to promote its e-cigarettes, new documents show

Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to

February 3, 2024

Protagonist drug hits goals in pivotal study of rare blood cancer

An experimental medicine from Protagonist Therapeutics stabilized red blood cells and improved symptoms in patients with a rare blood cancer — achieving the efficacy goals

March 3, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.